• Mashup Score: 0

    SpotlightBench to Bedside With SIDPC difficile COVID Vaccine Race PrEPClinicalView MoreCoronavirusAntimicrobial StewardshipBlood-Borne DiseasesFood-Borne InfectionsGastrointestinal InfectionsHealthcare-Associated InfectionsPreventionRespiratory DiseasesSexually Transmitted DiseasesSkin & Soft Tissue DiseasesZoonotic & Vector-Borne DiseasesVideo SeriesInsightsPeer ExchangePeers and…

    Tweet Tweets with this article
    • Are you interested in #antimicrobial stewardship and want to learn more? Check out our interviews and coverage from the recent #MADID2022 meeting. @MAD_ID_ASP https://t.co/GUVFIpDpK9

  • Mashup Score: 0

    Investigating RBX2660 for Recurrent C Difficile InfectionMay 24th 2022, 6:00pmMAD-ID | Making a Difference in Infectious DiseasesRBX2660, an investigational microbiota-based live biotherapeutic for the treatment of C difficile, safely and effectively reduced recurrent C diff for 6 months.Examining Oral Vancomycin as a First-Line CDI TherapyMay 24th 2022, 5:22pmMAD-IDWith limitations on…

    Tweet Tweets with this article
    • We are continuing to run our interviews from #MADID2022 so come check out our interviews and coverage from the meeting. @MAD_ID_ASP https://t.co/CLIykKKK2W